Funder
Frankfurt School of Finance & Management gGmbH
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Reference35 articles.
1. Paris V, Belloni A. Value in pharmaceutical pricing. OECD Health Working Papers, No. 63. OECD Publishing (2013). https://doi.org/10.1787/5k43jc9v6knx-en (Accessed Jan 25, 2019).
2. Bouvy J, Vogler S. Pricing and reimbursement policies: impacts on innovation. In: Kaplan W, Wirtz V, MantelTeuwisse A, Laing R, editors. Priority medicines for Europe and the world—2013 update. Geneva: World Health Organization; 2013.
3. Lomas J, Ochalek J, Faria R. Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment. Appl Health Econ Health Policy. 2022;20(1):13–8.
4. Sampson C, Zamora B, Watson S, Cairns J, Chalkidou K, Cubi-Molla P, Devlin N, García-Lorenzo B, Hughes DA, Leech AA, Towse A. Supply-side cost-effectiveness thresholds: questions for evidence-based policy. Appl Health Econ Health Policy. 2022;20(5):651–67.
5. Gandjour A. Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG. BMC Health Serv Res. 2020;20(1):343.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献